Ohio Public Employees Retirement System (OPERS)
LYEL icon

Ohio Public Employees Retirement System (OPERS)’s Lyell Immunopharma LYEL Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,715
Closed -$18.5K – 2348
2025
Q1 		$18.5K Sell
1,715
-3,250
-65% -$39.8K ﹤0.01% 2192
2024
Q4 		$63.6K Buy
+4,965
New +$98.4K ﹤0.01% 1878
2023
Q4 		– Sell
-1,360
Closed -$40K – 1987
2023
Q3 		$40K Buy
1,360
+711
+110% +$33.8K ﹤0.01% 1599
2023
Q2 		$41K Sell
649
-5,591
-90% -$309K ﹤0.01% 1607
2023
Q1 		$295K Buy
+6,240
New +$334K ﹤0.01% 1347

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s LYEL Position: Q2 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 1,715 shares — an estimated $18.5K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in LYEL in Q1 2023 and held it in 5 quarters. The position peaked at $295K in Q1 2023. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 1,715 Lyell Immunopharma shares in Q2 2025, an estimated $18.5K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Lyell Immunopharma in Q1 2023 and held it in 5 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Lyell Immunopharma position peaked at $295K in Q1 2023.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2025, filed 15 Jul 2025.